Core Capabilities
Precision Gene Editing
CRISPR-Cas9, base editing, and prime editing platforms optimized for high-fidelity genomic modifications in human and non-human cell lines.
Synthetic Biology & Metabolic Engineering
Design-build-test-learn cycles for engineered microbes and mammalian cells producing therapeutics, enzymes, and bio-based materials.
Cell & Gene Therapy Manufacturing
End-to-end CGT production: autologous/allogeneic T-cell processing, viral vector production, and closed-system bioprocessing.
Computational & AI-Driven Biology
Machine learning models for protein design, cellular behavior prediction, and automated lab optimization integrated with Zenth Digital Systems.
Cryopreservation & Cold Chain Logistics
Vitrification protocols, long-term cell banking, and integrated logistics with Aevum Global Logistics for global therapeutic distribution.
Regenerative Medicine & Biomaterials
Stem cell differentiation protocols, 3D bioprinting, and hydrogel scaffolds for tissue engineering and organ-on-chip platforms.
Research Pipeline
| Program | Indication / Application | Modality | Stage | Target |
|---|---|---|---|---|
| AZE-0124 | Refractory Solid Tumors | Allogeneic CAR-T | Phase II | 2027 Commercialization |
| AZE-0389 | Huntington's Disease | AAV-Gene Therapy | Preclinical | IND Filing 2026 |
| AZE-BIO-X7 | Industrial Enzyme Production | Engineered Yeast | Commercial | Active License |
| AZE-0551 | Type 1 Diabetes | Encapsulated β-Cell Therapy | Discovery | Lead Optimization |
| AZE-0220 | Cystic Fibrosis | Base-Edited Airway Epithelium | Phase I/II | 2028 Data Readout |
Manufacturing & Facilities
Zenth Cell Core Facility
Bioprocessing Hub
Discovery & Screening Lab
Cryogenic Storage Bank
Cross-Divisional Synergy
Zenth Digital Systems
Cloud-based lab data management, AI-driven protein folding prediction, and automated experimental design pipelines.
Aevum Global Logistics
Temper-controlled cold chain, autonomous last-mile delivery for autologous therapies, and real-time IoT tracking.
Aevum Capital Group
Strategic funding for high-risk/high-reward gene therapies, spin-out acquisitions, and biotech venture partnerships.
Advanced Research
Fundamental biology discovery, novel delivery vectors, and cross-pollination with aerospace biomaterials research.
Collaborate with Aevum Zenth Cell Engineering
Whether you're a biotech partner, academic institution, or healthcare provider, explore joint research agreements, CDMO services, or clinical trial participation.